Cassandra Moran, DO
Department / Division
Pediatrics /
Pediatrics-Hematology/Oncology
Address
DUMC 102382
Durham, NC 27710
Appointment Telephone
919-684-3401
Office Telephone
919-684-3401
Fax Telephone
919-681-7950
- DO, Philadelphia College of Osteopathic Medicine (Pennsylvania), 1999
- Pediatrics, Geisinger Medical Center (Pennsylvania), 1999-2002
- Pediatric Hematology/Oncology, UNC Hospitals, 2002-2005
- Post-Doctoral Research, University of North Carolina at Chapel Hill, 2004-2006
- Pediatric Pharmacology Research, Duke University Medical Center/University of North Carolina at Chapel Hill, 2003-Present
Clinical Interests
Pediatric oncology, experimental therapeutics/early drug development, pharmacokinetics of drugs used in children
Research Interests
Pediatric pharmacology and therapeutics
Pharmacokinetics of antimicrobials and chemotherapeutics used in children
Early drug development
This physician (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.
- Pfizer Inc.
Representative Publications
Cohen-Wolkowiez M, Benjamin DK Jr, Piper L, Cheifetz IM, Moran C, Liu P, Aram J, Kashuba AD, Capparelli E, Walsh TJ, Hope WW, Smith PB. Safety and pharmacokinetics of multiple-dose anidulafungin in infants and neonates. Clin Pharmacol Ther. 2011 May;89(5):702-7.
(2011)
Abstract
Moran C, Thornburg CD, Barfield RC. Ethical considerations for pharmacogenomic testing in pediatric clinical care and research. Pharmacogenomics. 2011 Jun;12(6):889-95.
(2011)
Abstract
Moran C, Benjamin D. Treatment of neonatal fungal infections. Adv Exp Med Biol. 2010;659:129-38.
(2010)
Abstract
Moran C, Smith PB, Cohen-Wolkowiez M, Benjamin DK Jr. Clinical trial design in neonatal pharmacology: effect of center differences, with lessons from the Pediatric Oncology Cooperative Research experience. Clin Pharmacol Ther. 2009 Dec;86(6):589-91.
(2009)
Abstract
